Uveal Melanoma Treated With Iodine-125 Episcleral Plaque According to the COMS Trial Is Associated With Worsened Visual Acuity Change and Increased Risk of Chronic Toxicity Compared to Lower Prescription Doses
Publication
, Conference
Perez, BA; Mettu, P; Vajzovic, L; Alkaissi, A; Steffey, BA; Cai, J; Stinnett, S; Mruthyunjaya, P; Kirsch, DG
Published in: International Journal of Radiation Oncology*Biology*Physics
September 2014
Duke Scholars
Published In
International Journal of Radiation Oncology*Biology*Physics
DOI
ISSN
0360-3016
Publication Date
September 2014
Volume
90
Issue
1
Start / End Page
S306 / S306
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 5105 Medical and biological physics
- 3407 Theoretical and computational chemistry
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 0299 Other Physical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Perez, B. A., Mettu, P., Vajzovic, L., Alkaissi, A., Steffey, B. A., Cai, J., … Kirsch, D. G. (2014). Uveal Melanoma Treated With Iodine-125 Episcleral Plaque According to the COMS Trial Is Associated With Worsened Visual Acuity Change and Increased Risk of Chronic Toxicity Compared to Lower Prescription Doses. In International Journal of Radiation Oncology*Biology*Physics (Vol. 90, pp. S306–S306). Elsevier BV. https://doi.org/10.1016/j.ijrobp.2014.05.1023
Perez, B. A., P. Mettu, L. Vajzovic, A. Alkaissi, B. A. Steffey, J. Cai, S. Stinnett, P. Mruthyunjaya, and D. G. Kirsch. “Uveal Melanoma Treated With Iodine-125 Episcleral Plaque According to the COMS Trial Is Associated With Worsened Visual Acuity Change and Increased Risk of Chronic Toxicity Compared to Lower Prescription Doses.” In International Journal of Radiation Oncology*Biology*Physics, 90:S306–S306. Elsevier BV, 2014. https://doi.org/10.1016/j.ijrobp.2014.05.1023.
Perez BA, Mettu P, Vajzovic L, Alkaissi A, Steffey BA, Cai J, et al. Uveal Melanoma Treated With Iodine-125 Episcleral Plaque According to the COMS Trial Is Associated With Worsened Visual Acuity Change and Increased Risk of Chronic Toxicity Compared to Lower Prescription Doses. In: International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2014. p. S306–S306.
Perez, B. A., et al. “Uveal Melanoma Treated With Iodine-125 Episcleral Plaque According to the COMS Trial Is Associated With Worsened Visual Acuity Change and Increased Risk of Chronic Toxicity Compared to Lower Prescription Doses.” International Journal of Radiation Oncology*Biology*Physics, vol. 90, no. 1, Elsevier BV, 2014, pp. S306–S306. Crossref, doi:10.1016/j.ijrobp.2014.05.1023.
Perez BA, Mettu P, Vajzovic L, Alkaissi A, Steffey BA, Cai J, Stinnett S, Mruthyunjaya P, Kirsch DG. Uveal Melanoma Treated With Iodine-125 Episcleral Plaque According to the COMS Trial Is Associated With Worsened Visual Acuity Change and Increased Risk of Chronic Toxicity Compared to Lower Prescription Doses. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2014. p. S306–S306.
Published In
International Journal of Radiation Oncology*Biology*Physics
DOI
ISSN
0360-3016
Publication Date
September 2014
Volume
90
Issue
1
Start / End Page
S306 / S306
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 5105 Medical and biological physics
- 3407 Theoretical and computational chemistry
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 0299 Other Physical Sciences